Antiparasitic activity of risedronate in a murine model of acute Chagas' disease

Luciana R. Garzoni, Mariana C. Waghabi, Marcos M. Baptista, Solange L. De Castro, Maria De Nazareth L. Meirelles, Constança C. Britto, Roberto Docampo, Eric Oldfield, Julio A. Urbina

Research output: Contribution to journalArticlepeer-review


We report the results of a study on the activity of the farnesyl-pyrophosphate synthase inhibitor risedronate (Ris) in a murine model of acute Chagas' disease. This compound displays rapid, cytocidal activity in vitro against Trypanosoma cruzi, but its in vivo activity had not been investigated previously. A murine model of acute Chagas' disease was used, in which experimental animals were infected with 103 trypomastigotes and intravenous treatment was started 24 h post-infection. In this model, Ris, at doses as low as 1 mg/kg per day given for 7 days, induced >90% reductions in parasitaemia and increased very significantly (P = 0.001) the survival of treated animals. Higher doses (up to 10 mg/kg per day) led to further reductions in parasitaemia and mortality, with no deleterious effects on weight gain and general physical condition of the treated animals. There was no relapse of parasitaemia after discontinuation of treatment, suggesting trypanocidal, rather than trypanostatic, activity. This interpretation was confirmed by the almost complete disappearance of amastigote nests in the hearts of treated animals. However, no parasitological cures were observed in infected animals that received the bisphosphonate, probably due to the short treatment period. Taken together, these results indicate that Ris could be a useful lead compound for the development of new drugs effective against Chagas' disease.

Original languageEnglish (US)
Pages (from-to)286-290
Number of pages5
JournalInternational Journal of Antimicrobial Agents
Issue number3
StatePublished - Mar 2004


  • Amastigote
  • Mouse model
  • Risedronate
  • Trypanocidal

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Antiparasitic activity of risedronate in a murine model of acute Chagas' disease'. Together they form a unique fingerprint.

Cite this